| Nov 13 |
Is Bicycle Therapeutics plc (BCYC) Top Performing European Stock Heading into 2025?
|
| Nov 12 |
Bicycle Therapeutics to Participate in the Jefferies London Healthcare Conference
|
| Nov 7 |
Bicycle Therapeutics: Looking Again At An Intriguing Developmental Concern
|
| Nov 2 |
Bicycle Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|
| Oct 31 |
Bicycle Therapeutics GAAP EPS of -$0.74 beats by $0.02, revenue of $2.68M misses by $4.33M
|
| Oct 31 |
Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results
|
| Oct 23 |
Bicycle Therapeutics Announces First Human Imaging Data from European Association of Nuclear Medicine 2024 Congress and Outlines Strategy for Leadership in Next-Generation Radiopharmaceuticals
|
| Oct 17 |
Bicycle Therapeutics (BCYC): High-Growth UK Stock with Innovative Peptide Technology
|
| Oct 16 |
Bicycle Therapeutics to Present Radiopharmaceuticals Data at European Association of Nuclear Medicine 2024 Congress
|
| Oct 14 |
Bicycle Therapeutics (BCYC) Soars 5.7%: Is Further Upside Left in the Stock?
|
